文献速递外周动脉疾病

BEST-CLI试验参与专科与全国外周动脉疾病治疗专家的比较

Comparison of specialties participating in the BEST-CLI trial to specialists treating peripheral arterial disease nationally.
PubMed 文献 · J Vasc Surg · 2019-01-01

该报告描述了BEST-CLI试验中参与研究的医生类型和比例,并与全国医疗保险索赔数据中治疗PAD的专科医生进行比较。截至2017年9月,共865名医生获得认证,其中血管外科医生占69%,多学科参与的中心占72%。试验中各专科进行血管内治疗的比例与全国模式相似,表明试验结果可能适用于真实世界实践。

要点

  • BEST-CLI试验认证医生以血管外科医生为主(69%),其大多同时具备开放手术和血管内治疗资质。
  • 72%的参与中心有多学科参与,28%仅由血管外科入组患者。
  • 试验中血管内治疗各专科比例与全国医疗保险数据相近,提示结果具有代表性。

核心结论

  • BEST-CLI试验包含了多样化的专科医生,其参与模式反映了全国PAD治疗模式,有助于确保试验结果适用于真实世界实践。

研究设计与样本

  • 通过审计10%的医疗保险索赔数据,比较BEST-CLI认证医生与全国治疗PAD的专科医生类型和比例。
  • BEST-CLI认证要求:血管内治疗需近2年完成至少12例膝下介入,开放手术需近2年完成至少10例膝下旁路手术。

主要发现

  • 截至2017年9月,共865名医生获得认证:血管外科医生596名(69%),介入心脏病医生128名(15%),介入放射科医生123名(14%),血管医学专家7名(1%),其他11名(1%)。
  • 596名血管外科医生中,113名(19%)仅开放手术,409名(69%)同时具备开放和血管内资质,3名(1%)仅血管内,71名有条件批准。
  • 136个参与中心中,98个(72%)有多学科参与,38个(28%)仅血管外科入组。
  • 血管内治疗专科比例(BEST-CLI vs 全国):血管外科55% vs 51%,介入心脏病17% vs 13%,介入放射16% vs 25%,其他2% vs 10%。

关键数值与推荐

  • 血管内治疗认证:近2年至少完成12例膝下介入。
  • 开放手术认证:近2年至少完成10例膝下旁路手术。
  • 执业第一年医生可有条件批准,需在完全批准医生监督下手术。

临床怎么用

  • BEST-CLI的专科参与模式与全国实践相似,支持将试验结果外推至真实世界PAD治疗。
  • 多学科参与常见,提示CLI管理常需血管外科、介入心脏病和介入放射科协作。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Best Endovascular vs Best Surgical Therapy for Patients with Critical Limb Ischemia (BEST-CLI) trial compares open surgery and endovascular therapy for the treatment of critical limb ischemia (CLI). This report describes the types and proportion of investigators participating in BEST-CLI and determines how these compare with those specialists treating peripheral artery disease (PAD) outside of the trial. METHODS: To be credentialed to enroll in BEST-CLI, investigators must be approved by the Surgical and Interventional Management Committee to have sufficient experience and skill in the management of patients with CLI. Investigators must attest to having completed at least 12 below-knee interventions in the last 2 years on CLI patients for endovascular approval and 10 lower extremity below-knee bypass procedures in the last 2 years for open surgical treatment. Investigators who met these criteria but were within their first year of practice were conditionally approved to do procedures under the oversight of a fully approved investigator. The type and proportion of specialists credentialed in BEST-CLI were compared with those treating PAD on a national basis by auditing 10% of Medicare claims for PAD. RESULTS: As of September 2017, a total of 865 physicians were credentialed to enroll in the BEST-CLI trial. Of these, 596 (69%) are vascular surgeons, 128 (15%) are interventional cardiologists, 123 (14%) are interventional radiologists, 7 (1%) are vascular medicine specialists, and 11 (1%) are other. Of the 596 vascular surgeons enrolling in the trial, 113 (19%) are credentialed for open surgery only, 409 (69%) are credentialed for both open surgery and endovascular therapy, and 3 (1%) are credentialed for only endovascular therapy. The remaining 71 participating vascular surgeons were conditionally approved. Of the 136 centers enrolling patients, multispecialty involvement is present in 98 (72%). In 38 (28%), vascular surgery alone is the service enrolling CLI patients. Endovascular treatment by specialty in BEST-CLI vs national Medicare claims is as follows: vascular surgery, 55% vs 51%; interventional cardiology, 17% vs 13%; interventional radiology, 16% vs 25%; and other, 2% vs 10%. CONCLUSIONS: BEST-CLI contains a diverse group of specialists enrolling and treating patients with CLI. Whereas a majority of the participating practitioners are vascular surgeons who do both open and endovascular procedures, a broad variety of specialists are represented in BEST-CLI in a pattern that represents national treatment patterns outside of the BEST-CLI trial. These treatment patterns will help ensure that findings from BEST-CLI are applicable to the real-world practice of treatments for PAD.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Powell R, Menard M, Farber A, et al. Comparison of specialties participating in the BEST-CLI trial to specialists treating peripheral arterial disease nationally. J Vasc Surg. 2019. PMID: 31010516. doi:10.1016/j.jvs.2018.08.188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。